We conducted a multicenter evaluation of commercial and in-house PCR method
s for the detection of enteroviruses. Three coded panels of test and contro
l RNA samples, artificial clinical specimens, and representative enteroviru
s serotypes were used to assess amplification methods, RNA extraction metho
ds, and reactivities with different enterovirus serotypes. Despite several:
differences between PCR methods, there was good agreement, although some v
ariation in sensitivity was observed. Most PCR methods were able to detect
enterovirus RNA derived from 0.01 50% tissue culture infective dose (TCID50
) and were able to detect at least 1 TCID50 of enterovirus in cerebrospinal
fluid, stool, or throat swab specimens. Most were also able to detect a wi
de range of enterovirus serotypes, although serotypic identification was no
t possible. Some laboratories experienced false-positive results due to PCR
contamination, which appeared to result mainly from cross-contamination of
specimens during RNA extraction. Provided that this problem is overcome, t
hese PCR methods will prove to be a sensitive and rapid alternative to cell
culture for the diagnosis of enterovirus infection.